LIGAND PHARMACEUTICALS INC's ticker is and the CUSIP is 53220KAF5. A total of 45 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $61,398,000 | +4.6% | 64,562,000 | 0.0% | 4.13% | -17.5% |
| Q3 2020 | $58,695,000 | -4.0% | 64,562,000 | -7.9% | 5.01% | -33.3% |
| Q2 2020 | $61,167,000 | +23.2% | 70,062,000 | +16.9% | 7.51% | +53.9% |
| Q1 2020 | $49,653,000 | -10.9% | 59,956,000 | -6.5% | 4.88% | -0.6% |
| Q4 2019 | $55,709,000 | +21.3% | 64,118,000 | +16.5% | 4.91% | +17.1% |
| Q3 2019 | $45,930,000 | +3.3% | 55,050,000 | +6.8% | 4.19% | +20.5% |
| Q2 2019 | $44,471,000 | – | 51,550,000 | – | 3.48% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CANYON CAPITAL ADVISORS LLC | 40,000,000 | $39,863,000 | 1.36% |
| TFG Asset Management GP Ltd | 21,600,000 | $21,837,000 | 1.32% |
| Penn Mutual Asset Management | 810 | $806,000 | 0.86% |
| WOLVERINE ASSET MANAGEMENT LLC | 47,643,000 | $47,931,000 | 0.45% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 11,645,000 | $11,750,000 | 0.25% |
| OAKTREE CAPITAL MANAGEMENT LP | 18,672,000 | $18,683,000 | 0.20% |
| PALISADE CAPITAL MANAGEMENT, LP | 9,833,000 | $9,883,000 | 0.20% |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 10,000,000 | $9,956,000 | 0.15% |
| SSI INVESTMENT MANAGEMENT LLC | 2,500,000 | $2,490,000 | 0.15% |
| AVIVA PLC | 31,500,000 | $31,724,000 | 0.13% |